Silverman promoted to CEO of mtm labs
This article was originally published in Clinica
Executive Summary
Bob Silverman has been promoted to CEO of mtm laboratories (Heidelberg, Germany), a developer and manufacturer of IVD devices for early detection and diagnosis of cervical cancer. Since 2005, he has been the chief commercial officer and president of the Westborough, Massachusetts firm's US subsidiary, where he will continue to be based. Former CEO Dr Peter Pack said that Mr Silverman's commercial strength and international expertise are the key qualities that recommended Mr Silverman to the leadership role.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.